The NSE findings of this study are consistent with the work by [23], who reported concentrations of 7.5 ± 1.5 ng/mL in controls, 15.2 ± 2.4 ng/mL in normoglycaemic stroke patients, and 19.7 ± 4.7 ng/mL in hyperglycaemic stroke patients. This evidence concerns the gene ENO2 and Stroke.